EuroDry Ltd., a dry bulk shipping company, received a buy rating following a strong Q2 net profit of $6.59 million driven mainly by higher charter rates rather than fleet expansion. The company plans a strategic fleet renewal that will increase capacity by nearly 49%, but faces risks related to capital commitments and funding. Maintaining high time charter equivalent (TCE) rates and avoiding shareholder dilution are key to unlocking long-term value for investors.
EuroDry's recent developments are presented here with Pluang's Industrials sector data as of Oct 28, 2026 21:11 WIB. Among 135 priced US Industrials stocks on Pluang, 67 rose and 67 fell today. Notable movers include ODFL at USD 177.20 with a -5.40% change and a typical hold time of 77 days, XYL at USD 87.93 with a -5.31% change and 97% buy order activity, and TRMD at USD 42.33 with a +4.86% change and 73% sell order activity. The most notable figure is XYL's 97% buy order activity.
On National First Responders Day, ADT celebrated local first responders and its monitoring professionals by unveiling a renovated monitoring center in Irving, Texas, part of a $2 million investment. The upgraded center features enhanced equipment and...
Presidio was named Enterprise Partner of the Year and Software and Services Partner of the Year for the Americas at the Cisco Partner Summit 2026. These awards recognize partners who excel in service and innovation, helping customers succeed through ...
Cobalt Boats unveiled the 2027 265 Coastal Edition, a fully redesigned luxury outboard runabout tailored for coastal boating enthusiasts. Featuring wood-free construction, enhanced comfort, and advanced technology like dual 9-inch displays and option...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
